We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVLV icon
676
Revolve Group
RVLV
$1.73B
$1.31M 0.01%
+37,929
New +$1.43M
PVH icon
677
PVH
PVH
$4.04B
$1.3M 0.01%
13,730
-349
-2% -$38.6K
WMGI
678
DELISTED
Wright Medical Group Inc
WMGI
$1.29M 0.01%
+43,343
New +$1.32M
ALBO
679
DELISTED
Albireo Pharma Inc
ALBO
$1.29M 0.01%
39,888
+14,544
+57% +$486K
FBP icon
680
First Bancorp
FBP
$4.38B
$1.28M 0.01%
+115,952
New +$1.25M
MOG.A icon
681
Moog Inc Class A
MOG.A
$12.8B
$1.28M 0.01%
13,651
+13,351
+4,450% +$1.19M
KEM
682
DELISTED
KEMET Corporation
KEM
$1.28M 0.01%
67,907
-98,905
-59% -$1.73M
TRVG
683
trivago
TRVG
$397M
$1.27M 0.01%
60,310
+20,054
+50% +$409K
FELE icon
684
Franklin Electric
FELE
$4.84B
$1.27M 0.01%
26,647
+25,483
+2,189% +$1.21M
LMNX
685
DELISTED
Luminex Corp
LMNX
$1.26M 0.01%
61,275
-6,542
-10% -$144K
TPTX
686
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.26M 0.01%
+30,942
New +$1.1M
OMP
687
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$1.26M 0.01%
58,493
+56,495
+2,828% +$1.14M
CDXS icon
688
Codexis
CDXS
$158M
$1.25M 0.01%
68,116
+23,644
+53% +$456K
DNKN
689
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$1.25M 0.01%
+15,693
New +$1.19M
ABMD
690
DELISTED
Abiomed Inc
ABMD
$1.25M 0.01%
4,790
-185,720
-97% -$49.3M
MIXT
691
DELISTED
MIX TELEMATICS LIMITED
MIXT
$1.25M 0.01%
82,817
+80,434
+3,375% +$1.33M
UNIT
692
Uniti Group
UNIT
$2.32B
$1.24M 0.01%
+130,338
New +$1.42M
KRNT icon
693
Kornit Digital
KRNT
$791M
$1.24M 0.01%
39,037
-27,287
-41% -$753K
Y
694
DELISTED
Alleghany Corp
Y
$1.23M 0.01%
1,802
+1,702
+1,702% +$1.13M
NATI
695
DELISTED
National Instruments Corp
NATI
$1.22M 0.01%
+28,967
New +$1.24M
GFF icon
696
Griffon
GFF
$4.86B
$1.21M 0.01%
71,771
-83,241
-54% -$1.42M
LILA icon
697
Liberty Latin America Class A
LILA
$1.67B
$1.21M 0.01%
109,761
-30,174
-22% -$369K
ONC
698
BeOne Medicines Ltd
ONC
$39.4B
$1.2M 0.01%
9,718
+9,140
+1,581% +$1.16M
STC icon
699
Stewart Information Services
STC
$2.08B
$1.2M 0.01%
+29,610
New +$1.26M
MORN icon
700
Morningstar
MORN
$7.53B
$1.19M 0.01%
8,244
+4,510
+121% +$623K
26 27
28
29 30

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.